About Fate Therapeutics
We are a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. Our pipeline is comprised of cell-based therapies for cancer and immune disorders. Our cellular immunotherapies are based on our novel ex vivo cell programming approach, which we apply to modulate the therapeutic function and direct the fate of hematopoietic cells.
State of Ownership
Technology enthusiast, self
Business Development Executive, Nature Publishing Group, Springer Nature
Sales Account Executive, Springer Nature
Business Development Executive, Nature Publishing Group